scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1020133467 |
P356 | DOI | 10.1038/SJ.GT.3302588 |
P698 | PubMed publication ID | 16034451 |
P5875 | ResearchGate publication ID | 7711709 |
P50 | author | David T. Curiel | Q64384545 |
P2093 | author name string | Kawakami Y | |
Mathis JM | |||
Bauerschmitz GJ | |||
Dall P | |||
Everts M | |||
Glasgow JN | |||
Le LP | |||
Pereboeva L | |||
Rivera AA | |||
Seigal GP | |||
Stoff A | |||
Stoff-Khalili MA | |||
Tsuruta Y | |||
P2860 | cites work | The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3 | Q33201422 |
An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism | Q33786008 | ||
Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway | Q33787309 | ||
Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector | Q33799667 | ||
Canine viral infections. | Q34061697 | ||
CAR chasing: canine adenovirus vectors-all bite and no bark? | Q35673359 | ||
Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. | Q35870225 | ||
Biophysical comparison of two canine adenoviruses | Q37140336 | ||
The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells | Q37340416 | ||
Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer | Q39588767 | ||
Longitudinal study of viruses associated with canine infectious respiratory disease | Q40180741 | ||
MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells | Q40545250 | ||
An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism | Q40548373 | ||
Bovine adenovirus type 3 containing heterologous protein in the C-terminus of minor capsid protein IX. | Q40579472 | ||
The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures | Q40992568 | ||
The avian adenovirus penton: two fibres and one base | Q42676747 | ||
Organ slice viability extended for pathway characterization: an in vitro model to investigate fibrosis | Q45085027 | ||
A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model | Q45858715 | ||
An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches | Q45859489 | ||
Sequence analysis of the canine adenovirus 2 fiber-encoding gene | Q45867827 | ||
A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity | Q45880319 | ||
Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses | Q45886201 | ||
Complete DNA sequence of canine adenovirus type 1. | Q48051797 | ||
Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors. | Q50895162 | ||
The 'blue eye' phenomenon | Q50929220 | ||
Detection and differentiation of CAV-1 and CAV-2 by polymerase chain reaction | Q64380068 | ||
Comparison of the immunological properties of two canine adenoviruses | Q64383152 | ||
A new instrument for the rapid preparation of tissue slices | Q71506932 | ||
Comparison of five incubation systems for rat liver slices using functional and viability parameters | Q73951905 | ||
P433 | issue | 23 | |
P921 | main subject | Adenoviridae | Q193447 |
gene therapy | Q213901 | ||
cancer gene therapy | Q124350675 | ||
P304 | page(s) | 1696-1706 | |
P577 | publication date | 2005-12-01 | |
P1433 | published in | Gene Therapy | Q15763095 |
P1476 | title | A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy | |
P478 | volume | 12 |
Q34268524 | A Phase I Study of a Tropism-Modified Conditionally Replicative Adenovirus for Recurrent Malignant Gynecologic Diseases |
Q34008026 | A conditionally replicative adenovirus, CRAd-S-pK7, can target endometriosis with a cell-killing effect |
Q37409025 | Adenoviral vector-based strategies for cancer therapy |
Q36419822 | Adenoviral vectors--how to use them in cancer gene therapy? |
Q33994011 | Adenovirus receptors and their implications in gene delivery |
Q36496709 | Adenovirus-mediated p53 tumor suppressor gene therapy of osteosarcoma |
Q40203638 | Combining high selectivity of replication via CXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast cancer |
Q41947416 | Enhanced Gene Delivery to Human Primary Endothelial Cells Using Tropism-Modified Adenovirus Vectors |
Q36692759 | Evolving gene therapy approaches for osteosarcoma using viral vectors: review |
Q34102305 | Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapy |
Q79239331 | Gene therapy for ovarian cancer |
Q57175561 | Improved Induction of Anti-Melanoma T Cells by Adenovirus-5/3 Fiber Modification to Target Human DCs |
Q40336666 | In vitro gene targeting in human hepatoblastoma. |
Q35620238 | Incorporation of porcine adenovirus 4 fiber protein enhances infectivity of adenovirus vector on dendritic cells: implications for immune-mediated cancer therapy |
Q89515608 | Infection and replication of human adenovirus type 3 possessing type 5 fiber protein in rodent cells |
Q36769180 | Oncolytic viruses in cancer therapy |
Q36387908 | Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds |
Q39971490 | Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver |
Q33700352 | Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy |
Q35609035 | Transductional targeting of adenovirus vectors for gene therapy |
Q38614156 | Tropism-modification strategies for targeted gene delivery using adenoviral vectors |
Search more.